与疾病修饰疗法坚持和多发性硬化症持续性相关的因素:一个范围广泛的文献综述
Aliza Bitton Ben-Zacharia1,2, Bryan Walker3, Amy Perrin Ross4
1From Bellevue School of Nursing, Hunter College, New York, NY, USA (AB-Z).
International journal of MS care
|September 18, 2023
概括
改善多发性硬化症 (MS) 疾病修饰疗法 (DMT) 的坚持和持续性至关重要. 老年和以前使用DMT对坚持有积极影响,而酒精消费和不良事件等因素对坚持有负面影响.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 多发性硬化症 (MS) 患者表现出广泛的坚持 (27.093.8%) 和持久性 (49.796.5%) 疾病修饰疗法 (DMT).
- 优化MS护理需要提高DMT的坚持和持续性.
- 了解相关因素可以改善多发性硬化症的治疗,并揭示研究缺陷.
研究的目的:
- 对影响多发性硬化症患者DMT坚持和持久性的因素进行范围文献综述.
- 分析有关此主题的现有文献的性质和发现.
主要方法:
- 包括用英语进行的定量临床研究,重点关注依从性或持续性作为主要结局.
- 分析了与坚持/持久性相关的因素,并按DMT类型分类:自注射,口服和输液.
- 审查了58项涉及103,450名患者的研究.
主要成果:
- 大多数研究都集中在可自我注射的DMT上 (n=41).
- 高龄和以前使用DMT与增加的坚持/持久性相关.
- 与坚持/坚持的负面关联包括酒精消费,DMT不良事件,高等教育和更高的BMI.
- 复发频率/严重程度增加了坚持,但减少了持久性.
结论:
- 需要对口服和输液DMT的粘附/持久性因子进行进一步的研究.
- 识别可修改的因素可以指导治疗决策.
- 改善的坚持和持久性可以导致MS患者更好的临床结果.
相关概念视频
Drug Therapy
68
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
68
Factors Influencing Drug Absorption: Disease States and Pharmacology
559
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
559
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
82
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
82
Factors Affecting Illness
4.3K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
4.3K
Factors Affecting Protein-Drug Binding: Drug-Related Factors
140
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
140


